MX343386B - Proteinas de fusion portadoras de peptido como vacunas para alergia. - Google Patents

Proteinas de fusion portadoras de peptido como vacunas para alergia.

Info

Publication number
MX343386B
MX343386B MX2013014439A MX2013014439A MX343386B MX 343386 B MX343386 B MX 343386B MX 2013014439 A MX2013014439 A MX 2013014439A MX 2013014439 A MX2013014439 A MX 2013014439A MX 343386 B MX343386 B MX 343386B
Authority
MX
Mexico
Prior art keywords
fusion proteins
peptide carrier
allergy vaccines
carrier fusion
polypeptide
Prior art date
Application number
MX2013014439A
Other languages
English (en)
Other versions
MX2013014439A (es
Inventor
Niespodziana Katarzyna
Focke-Tejkl Margarete
Vrtala Susanne
Banerjee Srinita
Chen Kuan-Wei
Weber Milena
Valenta Rudolf
Marth Katharina
Original Assignee
Biomay Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomay Ag filed Critical Biomay Ag
Publication of MX2013014439A publication Critical patent/MX2013014439A/es
Publication of MX343386B publication Critical patent/MX343386B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un polipéptido que comprende una secuencia de aminoácidos seleccionada del grupo que consiste de SEQID NO: 14, SE ID NO: 15, SEQ ID NO: 16 SEQ IDE NO: 17, SE ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 149, SEQ ID NO: 150, SEQ ID NO: 151 y SEQ ID NO: 152.
MX2013014439A 2011-06-09 2012-06-11 Proteinas de fusion portadoras de peptido como vacunas para alergia. MX343386B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11169365 2011-06-09
PCT/EP2012/061040 WO2012168487A1 (en) 2011-06-09 2012-06-11 Peptide carrier fusion proteins as allergy vaccines

Publications (2)

Publication Number Publication Date
MX2013014439A MX2013014439A (es) 2014-07-24
MX343386B true MX343386B (es) 2016-11-03

Family

ID=46354215

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014439A MX343386B (es) 2011-06-09 2012-06-11 Proteinas de fusion portadoras de peptido como vacunas para alergia.

Country Status (17)

Country Link
US (2) US9308251B2 (es)
EP (1) EP2717910B1 (es)
JP (1) JP6170912B2 (es)
CN (1) CN103687617B (es)
AU (1) AU2012266246B2 (es)
BR (1) BR112013031505B1 (es)
CA (1) CA2838217C (es)
DK (1) DK2717910T3 (es)
ES (1) ES2720140T3 (es)
HU (1) HUE042761T2 (es)
MX (1) MX343386B (es)
PL (1) PL2717910T3 (es)
PT (1) PT2717910T (es)
RU (1) RU2630652C2 (es)
TR (1) TR201905619T4 (es)
WO (1) WO2012168487A1 (es)
ZA (1) ZA201309399B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT503530A1 (de) * 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
PT2717910T (pt) * 2011-06-09 2019-05-22 Biomay Ag Proteínas de fusão transportadoras de péptido como vacinas para alergia
PL2723373T3 (pl) * 2011-06-27 2017-11-30 Anergis S.A. Sąsiadujące nakładające się peptydy do leczenia alergii na pyłek ambrozji
WO2015100360A1 (en) 2013-12-23 2015-07-02 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
WO2015185767A1 (es) * 2014-06-04 2015-12-10 Abbcn, S.L. Etiquetas peptídicas para el marcaje de proteínas por fusión, y anticuerpos para su detección
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
EP3138579A1 (en) * 2015-09-05 2017-03-08 Biomay Ag Fusion protein for use in the treatment of a hepatitis b virus infection
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
EP3295956A1 (en) 2016-09-20 2018-03-21 Biomay Ag Polypeptide construct comprising fragments of allergens
CN110325202B (zh) * 2016-10-31 2023-10-31 佐治亚州立大学研究基金会公司 乙型肝炎病毒pre-S蛋白的病毒样颗粒
EP3569612A1 (en) 2018-05-18 2019-11-20 Biomay Ag Treatment and prevention of house dust mite allergies
RU2761431C9 (ru) * 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии
EP4134674A1 (en) 2021-08-13 2023-02-15 Euroimmun Medizinische Labordiagnostika AG Methods and reagents for detecting an antibody to a ses ipr-10 allergen
CN118019754A (zh) 2021-09-23 2024-05-10 维拉瓦克斯股份公司 诱导pres特异性中和抗体的hbv疫苗
WO2023242436A1 (en) 2022-06-17 2023-12-21 Danmarks Tekniske Universitet Allergy vaccines based on consensus allergens
WO2024098216A1 (en) * 2022-11-07 2024-05-16 Worg Pharmaceuticals (Zhejiang) Co., Ltd Vaccine for treating allergies
CN116726198B (zh) * 2023-03-13 2024-02-13 陕西师范大学 一种抗肿瘤药物及其在脑胶质瘤治疗中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
RU2285042C2 (ru) * 2000-11-16 2006-10-10 Альк-Абелло А/С Новые мутантные аллергены
US20060121468A1 (en) 2002-06-26 2006-06-08 Allnutt F C T Viruses and virus-like particles for multiple antigen and target display
CN1665528B (zh) 2002-07-05 2013-05-15 弗利亚生物技术公司 佐剂病毒颗粒
AT503530A1 (de) 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
US20090214593A1 (en) * 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
EP2295076A1 (en) * 2009-09-10 2011-03-16 Biomay Ag Hypoallergenic hybrid polypeptides for the treatment of allergy
PT2717910T (pt) * 2011-06-09 2019-05-22 Biomay Ag Proteínas de fusão transportadoras de péptido como vacinas para alergia

Also Published As

Publication number Publication date
ES2720140T3 (es) 2019-07-18
CA2838217C (en) 2022-11-01
HUE042761T2 (hu) 2019-07-29
US9308251B2 (en) 2016-04-12
US20150335735A1 (en) 2015-11-26
PT2717910T (pt) 2019-05-22
CN103687617A (zh) 2014-03-26
AU2012266246A1 (en) 2014-01-09
BR112013031505A2 (pt) 2018-06-26
JP6170912B2 (ja) 2017-07-26
ZA201309399B (en) 2016-03-30
BR112013031505B1 (pt) 2023-01-10
TR201905619T4 (tr) 2019-05-21
CN103687617B (zh) 2017-09-15
EP2717910B1 (en) 2019-01-23
JP2014518635A (ja) 2014-08-07
MX2013014439A (es) 2014-07-24
RU2013157115A (ru) 2015-07-20
EP2717910A1 (en) 2014-04-16
US9844591B2 (en) 2017-12-19
PL2717910T3 (pl) 2019-07-31
CA2838217A1 (en) 2012-12-13
AU2012266246B2 (en) 2017-05-11
WO2012168487A1 (en) 2012-12-13
RU2630652C2 (ru) 2017-09-11
DK2717910T3 (en) 2019-04-15
US20140193450A1 (en) 2014-07-10

Similar Documents

Publication Publication Date Title
MX343386B (es) Proteinas de fusion portadoras de peptido como vacunas para alergia.
WO2013142859A3 (en) Fusion proteins of superfolder green fluorescent protein and use thereof
PH12015502612B1 (en) Influenza virus vaccines and uses thereof
MX2017006866A (es) Pares de unión para producción de péptidos.
EA201791238A1 (ru) Способы и композиции, в которых используются варианты полипептидов klotho
RU2021134101A (ru) Модифицированная j-цепь
EA033386B1 (ru) Рекомбинантные иммуногенные полипептиды стеблевого домена гемагглютинина вируса гриппа а и их применение
ES2676499T3 (es) Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones
CY1118856T1 (el) Εμβολιο pcsk9
WO2010117760A3 (en) Fusion proteins comprising canine fc portions
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
EA201491277A1 (ru) Противораковый слитый белок
MX2011008759A (es) Medios y metodos para fabricar neurotoxina altamente pura.
IN2014DN09815A (es)
MX2013007872A (es) Proteina de fusion anticancer.
JP2015524403A5 (es)
NZ629309A (en) Tumour necrosis factor receptor fusion proteins and methods of using the same
NZ724196A (en) Uti fusion proteins
EA201492068A1 (ru) Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии
MX365560B (es) Proteinas quimericas basadas en cyaa que comprenden un polipeptido heterologo y sus usos en la induccion de respuestas inmunes.
MX361861B (es) Proteínas de fusión propéptido-luciferasa y método de uso de las mismas.
MX2018002616A (es) Proteina de fusion.
WO2013054110A3 (en) Compositions for binding to amyloid proteins
MX2013007007A (es) Vacunas a base de peptidos de la proteina c5a de complemento.
NZ706202A (en) Peptide antagonists of the vasopressin-2 receptor

Legal Events

Date Code Title Description
FG Grant or registration